In January, the FDA approved Masimo SET-powered MightySat Medical Pulse Oximeter to be sold over-the-counter without prescription. In December 2023, Masmo received the FDA clearance for Stork for ...

Our mission is to improve life, improve patient outcomes; and reduce the cost of care. Masimo SET ® Measure-through Motion and Low Perfusion ™ pulse oximetry, introduced in 1995, has been shown in ...

Offers optional dual IBP, and EtCo 2 — Now with Masimo SET ® Pulse Oximetry! The fully-functional Waveline Touch features a 12.1" color TFT display with a touch-screen interface. It features ...

A special order item will need to ship to our warehouse from the manufacturer before then shipping to you. The estimated delivery range that you see is based on the information that we receive from ...

If you're looking for a fresh pick that's set to soar in the near-term, make sure to keep Masimo on your short list. Our team of experts has just released the 5 stocks with the greatest ...

Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointe ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...

"Katie’s more than 35 years of relevant experience and her unique mix of expertise set her apart during our search and make her an ideal fit to lead the next innovation-focused stage of Masimo ...